Skip to main content
Fig. 6 | BMC Musculoskeletal Disorders

Fig. 6

From: Treatment of critically sized femoral defects with recombinant BMP-2 delivered by a modified mPEG-PLGA biodegradable thermosensitive hydrogel

Fig. 6

Intracutaneous irritation test. (a) Diagram of arrangement of injection sites for tested samples (including normal saline and the BOX hydrogel at 20, 25 and 30 wt%) in rabbits. (b) Five intradermal injections of each 0.2 ml normal saline or the BOX hydrogel with different formulations (20, 25 and 30 wt%) were given to the fur-clipped skin of rabbits (N = 3). The skin irritation was evaluated at day 1, 2 and 3 after injection

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us